Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: Insights from the British Cardiovascular Intervention Society database.
Alex SirkerChun Shing KwokEvangelos KontopantelisTom JohnsonPhilip FreemanMark A de BelderPeter LudmanAzfar ZamanMamas A MamasPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
Our real world national study provides no clear evidence to indicate that use of potent P2Y12 blockers in SVG PCI is associated with improved clinical outcomes.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- acute myocardial infarction
- acute coronary syndrome
- adverse drug
- antiplatelet therapy
- randomized controlled trial
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- atrial fibrillation
- quality improvement
- coronary artery bypass grafting
- emergency department
- heart failure
- drug induced
- angiotensin ii